New Method for Detecting Circulating Tumor Cells in Cancer Patients
Author Information
Author(s): Liu Zhian, Fusi Alberto, Klopocki Eva, Schmittel Alexander, Tinhofer Ingeborg, Nonnenmacher Anika, Keilholz Ulrich
Primary Institution: Charité, Berlin, Germany
Hypothesis
Can a negative enrichment method improve the detection of circulating tumor cells (CTCs) in cancer patients?
Conclusion
Using CD45 depletion for enriching CTCs allows for the detection of cancer cells that do not show the classical epithelial phenotype, potentially leading to a more accurate estimation of CTC numbers.
Supporting Evidence
- CTCs were detected in 56% of blood samples from carcinoma patients.
- Detection rates increased to 73% when defining CTCs as CD45-CK+ and/or EpCAM+.
- CTCs were successfully cultured and passaged for over six months.
Takeaway
The study found a better way to find cancer cells in the blood by removing certain white blood cells, which helps doctors see more cancer cells that might be hiding.
Methodology
A two-step protocol was developed for processing blood samples, involving red blood cell lysis followed by leukocyte depletion and flow cytometry for CTC detection.
Potential Biases
Potential bias in sample selection and the reliance on specific markers for CTC identification.
Limitations
The study's findings may not apply to all cancer types, and the small sample size limits generalizability.
Participant Demographics
Patients included 48 with metastatic carcinomas and 22 with metastatic melanoma.
Statistical Information
P-Value
0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website